Florida 2023 Regular Session Status: In Committee Bipartisan · 3 D · 2 R cosponsors

HB 963 — HIV Infection Prevention Drugs

Last action — Died in Healthcare Regulation Subcommittee

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2023 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

HIV Infection Prevention Drugs; Authorizes certain licensed pharmacists to screen for HIV exposure & order & dispense HIV infection prevention drugs in accordance with certain written supervisory protocol or statewide drug therapy protocol; requires Board of Pharmacy, in consultation with Board of Medicine & Board of Osteopathic Medicine, to adopt rules & develop certain statewide drug therapy protocol.

Bill Text

Action History

  1. Died in Healthcare Regulation Subcommittee

  2. 1st Reading (Original Filed Version)

  3. Now in Healthcare Regulation Subcommittee

  4. Referred to Health & Human Services Committee

  5. Referred to Health Care Appropriations Subcommittee

  6. Referred to Healthcare Regulation Subcommittee

  7. Filed

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 3 co-sponsors · 159 not signed on

Sponsors (2)

Co-sponsors (3)

Not signed on (159)

159 members have not signed on to this bill.

Show all 159 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 963 do?
HIV Infection Prevention Drugs; Authorizes certain licensed pharmacists to screen for HIV exposure & order & dispense HIV infection prevention drugs in accordance with certain written supervisory protocol or statewide drug therapy protocol; requires Board of Pharmacy, in consultation with Board of Medicine & Board of Osteopathic Medicine, to adopt rules & develop certain statewide drug therapy protocol.
Who sponsors HB 963?
HB 963 is sponsored by Joseph, Dotie (Democrat), Chambliss, Kevin D. (Democrat), Basabe, Fabián (Republican), Franklin II, Gallop (Democrat), and Lopez, Vicki L. (Republican).
What is the current status of HB 963?
This bill died with 2023 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 963?
Track HB 963 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 963

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 963

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →